0 items USD 0.00Search
Your search for "Pharma Pipeline" gave back 90 results.
T-Cell & NK-Cell Engaging Bispecific Antibo dies 2019: a business, stakeholder, technology and pipeline analysis report provides you with a...
颁补迟补濒辞驳:听
La Merie Publishing
June 2019
Price: USD 2,700.00
鈥淣on-alcoholic steatohepataitis (NASH) Pipeline Analysis鈥� gives comprehensive insights on the various drugs being developed for the treatment of NASH...
IQ4I
October 2019
Price: USD 3,600.00
Innovation Tracking Factbook 2018: An Assessment of the Pharmaceutical Pipeline Summary GBI Research鈥檚 latest report 鈥淚nnovation Tracking Factbook...
颁补迟补濒辞驳:听
CBR Pharma Insights
December 2018
Price: USD 2,995.00
The Mid-Size Pharmaceutical 麻豆原创: 麻豆原创 Assessment, Growth Forecasts and Strategic Consolidations for Key Players Summary GBI Research鈥檚 latest...
颁补迟补濒辞驳:听
CBR Pharma Insights
May 2018
Price: USD 2,995.00
鈥淟utetium-177 Global 麻豆原创 Analysis鈥� gives comprehensive insights on the various Lu-177 based drugs being developed for the treatment of GEP-NET,...
IQ4I
February 2020
Price: USD 3,600.00
PI3K Signaling Pathway Analysis: A Shifting 麻豆原创ed and Pipeline Product Landscape, as Blockbusters Expire and Development Moves Towards Downstream...
颁补迟补濒辞驳:听
CBR Pharma Insights
July 2018
Price: USD 2,995.00
The report entitled 鈥濧ntibody-Drug Conjugates 2014 鈥� A Business, Technology & Pipeline Analysis鈥� published in January 2014 is based on the...
颁补迟补濒辞驳:听
La Merie Publishing
January 2014
Price: USD 2,298.00
Emerging Gene Therapies - Trends within the Technological, Clinical, Regulatory and Competitive Landscape Summary GBI Research鈥檚 latest report 鈥�...
颁补迟补濒辞驳:听
CBR Pharma Insights
January 2019
Price: USD 2,995.00
Global Biosimilars 麻豆原创 - Increasingly Lucrative 麻豆原创 Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics...
颁补迟补濒辞驳:听
CBR Pharma Insights
January 2019
Price: USD 2,995.00
This report provides a landscape description and analysis of chimeric antigen receptor-macrophage (CAR-M) platform technologies and stakeholders from...
颁补迟补濒辞驳:听
La Merie Publishing
February 2023
Price: USD 2,000.00
Report Package: Bispecific Antibodies This report package includes the full report T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a...
颁补迟补濒辞驳:听
La Merie Publishing
July 2019
Price: USD 2,840.00
Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players Summary GBI Research鈥檚 latest report,...
颁补迟补濒辞驳:听
CBR Pharma Insights
October 2018
Price: USD 2,995.00
This report provides you with a landscape description and analysis of discovery and development of claudin 18.2 (CLDN18.2)-targeted antibody and cell...
颁补迟补濒辞驳:听
La Merie Publishing
August 2023
Price: USD 2,365.00
Important bispecific antibody targets are basically in clinical practice, and many momentous bispecific antibodies will be born in the future. The...
颁补迟补濒辞驳:听
AEI
June 2021
Price: USD 3,000.00
The report TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016: Convergence of technologies opens business opportunities beyond CD19 CARTs...
颁补迟补濒辞驳:听
La Merie Publishing
June 2016
Price: USD 2,750.00
听
